Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 44
Filtrar
1.
Physiol Res ; 63(5): 659-66, 2014.
Artículo en Inglés | MEDLINE | ID: mdl-24908084

RESUMEN

The effects of environmental salinity on physiological responses, growth, and survival of the Gulf corvina, C. othonopterus, were evaluated in a 6-week completely randomized design experiment. Corvina (17.2+/-2.3 g mean initial body weight) were subjected to salinities of 5, 15, 25, and 35 ‰ and fed a commercial feed with protein and lipid contents of 46 and 14 %, respectively. Plasma osmolality increased significantly with salinity, ranging from 335.1+/-5.3 mOsm/kg in fish maintained at 5 ‰, to 354.8+/-6.8 mOsm/kg in fish kept in seawater, while a significant inverse relationship was observed between salinity and moisture content of whole fish, ranging from 73.8+/-0.7 (measured at 5 ‰) to 76.9+/-1.0 % (measured at 35 ‰). In spite of this, growth indices (final weight, weight gain, specific growth rate, condition factor, survival) were not altered, suggesting that, like other members of the family Sciaenidae, the Gulf corvina is a strong osmoregulator. The isosmotic point for this species was estimated to correspond to a salinity of 9.8 ‰. The present study represents the first set of experimental data on salinity tolerance of C. othonopterus and confirms the euryhalinity of this species.


Asunto(s)
Explotaciones Pesqueras , Osmorregulación , Perciformes/fisiología , Salinidad , Agua de Mar/química , Alimentación Animal , Animales , Perciformes/crecimiento & desarrollo , Factores de Tiempo , Aumento de Peso
2.
Colorectal Dis ; 16(9): 710-8; discussion 718, 2014 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-24836541

RESUMEN

AIM: Colonic epithelial dysplasia is deemed the precursor lesion of cancer arising in inflammatory bowel disease (IBD). It has been suggested that many dysplastic lesions could be endoscopically detected to obtain target biopsies, leading to better yield. However, the clinical impact of a diagnosis of dysplasia may be hampered by a significant degree of histological and endoscopic intra-observer and inter-observer variability. This study aimed to evaluate intra-observer and inter-observer variability in the microscopic diagnosis of dysplasia in IBD and correlate endoscopic and histological findings. METHOD: In total, 158 cases of ulcerative colitis and 14 of Crohn's disease with dysplasia were selected from a pathology database. Slides were blindly reviewed twice by two expert gastrointestinal pathologists. Results of endoscopic examinations were extracted from the reports. The degree of intra-observer and inter-observer variability was determined by kappa statistics. RESULTS: Overall, there was an excellent degree of histopathological inter-observer agreement (κ = 0.786). The lowest level of agreement in the dysplasia group was for indefinite dysplasia (κ = 0.251). Negative and high grade dysplasia diagnosis reached the highest level of agreement with κ values of 0.822 [95% confidence interval (CI) 0.673-0.971] and 1.00 (95% CI 0.850-1.149), respectively. Intra-observer agreement was good and increased during the latter period of the study (κ = 0.734, 95% CI 0.642-0.826). Endoscopic-histological correlation was poor among the negative endoscopies, as up to 43% of cases were diagnosed with at least focal high grade dysplasia. The endoscopic-histological correlation improved when evaluating suspicious endoscopic lesions. CONCLUSION: Dysplasia is reliably diagnosed by expert gastrointestinal pathologists but has poor correlation with an endoscopic diagnosis of dysplasia.


Asunto(s)
Adenocarcinoma/patología , Colon/patología , Neoplasias del Colon/patología , Enfermedades Inflamatorias del Intestino/patología , Lesiones Precancerosas/patología , Biopsia , Colonoscopía , Humanos , Variaciones Dependientes del Observador , Estudios Retrospectivos , Método Simple Ciego
3.
Colorectal Dis ; 16(9): 703-9, 2014 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-24787457

RESUMEN

AIM: This study aimed to compare the clinical outcome between local excision (LE) and total mesorectal excision (TME) for early rectal cancer. METHOD: After Institutional Review Board approval, charts of patients with T1 or T2 N0M0 rectal adenocarcinoma treated by curative LE or TME without preoperative radiotherapy from 2004 to 2012 were reviewed. Categorical and continuous variables were compared using chi-square analysis and the ANOVA test. Kaplan-Meier analysis compared survival rates. RESULTS: The study included 153 patients: 79 underwent TME and 74 LE. Postoperative infection was more common after TME (P = 0.009). There was tumour involvement of the margins in 13.5% after LE compared with 0% after TME (P = 0.001). Of the patients treated initially by LE, 13.5% had additional surgery for unfavourable histological findings and 4.1% had residual tumour. Median follow up was 35 (17-96) months. No deaths were recorded in 56 patients with a pT1 lesion. There was no significant difference in local recurrence (P = 0.332) or 3-year disease-free survival (DFS; P = 0.232) between patients having LE or TME. The 68 patients with a T2 lesion had higher local recurrence (P = 0.025) and lower DFS following LE compared with TME (P = 0.044). There was no difference in overall survival (P = 0.351). CONCLUSION: LE of early rectal cancer is associated with higher local recurrence and decreased DFS. These disadvantages are significant for T2 lesions.


Asunto(s)
Adenocarcinoma/cirugía , Microcirugia , Cirugía Endoscópica por Orificios Naturales , Neoplasias del Recto/cirugía , Recto/cirugía , Adenocarcinoma/mortalidad , Adenocarcinoma/patología , Adulto , Anciano , Anciano de 80 o más Años , Femenino , Estudios de Seguimiento , Humanos , Estimación de Kaplan-Meier , Modelos Logísticos , Masculino , Persona de Mediana Edad , Recurrencia Local de Neoplasia/etiología , Recurrencia Local de Neoplasia/prevención & control , Estadificación de Neoplasias , Neoplasias del Recto/mortalidad , Neoplasias del Recto/patología , Estudios Retrospectivos , Tasa de Supervivencia , Resultado del Tratamiento
4.
Oncogene ; 32(18): 2335-45, 2013 May 02.
Artículo en Inglés | MEDLINE | ID: mdl-22733134

RESUMEN

Considerable interest has been generated from the results of recent clinical trials using smoothened (SMO) antagonists to inhibit the growth of hedgehog (HH) signaling-dependent tumors. This interest is tempered by the discovery of SMO mutations mediating resistance, underscoring the rationale for developing therapeutic strategies that interrupt HH signaling at levels distinct from those inhibiting SMO function. Here, we demonstrate that HH-dependent non-small cell lung carcinoma (NSCLC) growth is sensitive to blockade of the HH pathway upstream of SMO, at the level of HH ligand processing. Individually, the use of different lentivirally delivered shRNA constructs targeting two functionally distinct HH-processing proteins, skinny hedgehog (SKN) or dispatched-1 (DISP-1), in NSCLC cell lines produced similar decreases in cell proliferation and increased cell death. Further, providing either an exogenous source of processed HH or a SMO agonist reverses these effects. The attenuation of HH processing, by knocking down either of these gene products, also abrogated tumor growth in mouse xenografts. Finally, we extended these findings to primary clinical specimens, showing that SKN is frequently overexpressed in NSCLC and that higher DISP-1 expression is associated with an unfavorable clinical outcome. Our results show a critical role for HH processing in HH-dependent tumors, identifies two potential druggable targets in the HH pathway, and suggest that similar therapeutic strategies could be explored to treat patients harboring HH ligand-dependent cancers.


Asunto(s)
Aciltransferasas/metabolismo , Carcinoma de Pulmón de Células no Pequeñas/metabolismo , Carcinoma de Pulmón de Células no Pequeñas/patología , Proteínas Hedgehog/metabolismo , Neoplasias Pulmonares/metabolismo , Neoplasias Pulmonares/patología , Proteínas de la Membrana/metabolismo , Aciltransferasas/genética , Secuencia de Aminoácidos , Animales , Carcinoma de Pulmón de Células no Pequeñas/genética , Carcinoma de Pulmón de Células no Pequeñas/mortalidad , Línea Celular Tumoral , Supervivencia Celular , Proteínas Hedgehog/genética , Humanos , Neoplasias Pulmonares/genética , Neoplasias Pulmonares/mortalidad , Proteínas de la Membrana/genética , Ratones , Ratones Transgénicos , Datos de Secuencia Molecular , Conejos , Receptores Acoplados a Proteínas G/genética , Receptores Acoplados a Proteínas G/metabolismo , Transducción de Señal/genética , Receptor Smoothened , Ensayos Antitumor por Modelo de Xenoinjerto
5.
Transplant Proc ; 43(7): 2814-6, 2011 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-21911170

RESUMEN

BACKGROUND: Hepatopulmomary syndrome is defined by the triad of chronic liver disease, increased alveolar-arterial gradient, and evidence of intrapulmonary vasodilation. It is commonly seen in association with cirrhosis (90%). Four percent to 8% of the hepatopulmomary syndrome cases are reported in noncirrhotic portal hypertension. The management of patients with hepatopulmomary syndrome due to noncirrhotic portal hypertension is not well described. METHODS: We report a case of a 26-year-old woman who underwent liver transplantation for hepatopulmomary syndrome due to noncirrhotic portal hypertension. The patient presented with dyspnea and platypnea, requiring home oxygen therapy. She had orthodexia, severe hypoxemia, and positive bubble echocardiography consistent with hepatopulmomary syndrome. Her Model for End-stage Liver Disease score was 10. Liver biopsy revealed diffuse nodular regenerative hyperplasia. RESULTS: The patient underwent liver transplantation with Model for End-stage Liver Disease exception points. Her oxygen requirements gradually improved during the postoperative period. The patient's symptoms and hypoxemia resolved at 15-month follow-up posttransplantation. CONCLUSION: We suggest hepatopulmonary syndrome in this setting is an indication for liver transplantation despite the absence of cirrhosis.


Asunto(s)
Síndrome Hepatopulmonar/cirugía , Hipertensión Portal/cirugía , Trasplante de Hígado , Adulto , Femenino , Síndrome Hepatopulmonar/complicaciones , Humanos , Hipertensión Portal/complicaciones
6.
Transpl Infect Dis ; 10(4): 280-5, 2008 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-18069931

RESUMEN

Gas gangrene is a rare and devastating infectious process that can occur after liver transplantation, most often following hepatic artery thrombosis. We here report 3 cases of gas gangrene following orthotopic liver transplantation. Blood cultures were positive for Clostridium clostridiiforme in one case. In 2 other cases liver tissue from explanted specimens was positive for Enterobacter cloacae. Ultrasound demonstrated hepatic artery thrombosis and computed tomography imaging revealed diffuse liver necrosis with gas formation in each case. All 3 patients were successfully treated with a combination of antibiotics and emergent re-transplantation. We review previously published cases of gas gangrene after liver transplant and emphasize the importance of hepatic artery thrombosis in the development of this syndrome as well as the frequent involvement of non-clostridial organisms. Early diagnosis and aggressive combined medical and surgical treatment including re-transplantation are essential for successful treatment of these rare and catastrophic infections.


Asunto(s)
Infecciones por Clostridium , Infecciones por Enterobacteriaceae , Gangrena Gaseosa/tratamiento farmacológico , Gangrena Gaseosa/microbiología , Hepatopatías , Trasplante de Hígado/efectos adversos , Antibacterianos/uso terapéutico , Sangre/microbiología , Clostridium/aislamiento & purificación , Infecciones por Clostridium/complicaciones , Infecciones por Clostridium/diagnóstico , Infecciones por Clostridium/tratamiento farmacológico , Infecciones por Clostridium/microbiología , Medios de Cultivo , Enterobacter cloacae/aislamiento & purificación , Infecciones por Enterobacteriaceae/complicaciones , Infecciones por Enterobacteriaceae/diagnóstico , Infecciones por Enterobacteriaceae/tratamiento farmacológico , Infecciones por Enterobacteriaceae/microbiología , Femenino , Gangrena Gaseosa/diagnóstico por imagen , Gangrena Gaseosa/etiología , Arteria Hepática/cirugía , Humanos , Hepatopatías/diagnóstico por imagen , Hepatopatías/tratamiento farmacológico , Hepatopatías/microbiología , Masculino , Persona de Mediana Edad , Radiografía , Trombosis/diagnóstico por imagen , Trombosis/etiología , Trombosis/cirugía , Resultado del Tratamiento
7.
Surg Endosc ; 21(4): 560-9, 2007 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-17180281

RESUMEN

BACKGROUND: This study aimed to determine the optimal treatment parameters for the ablation of intestinal metaplasia (IM) containing high-grade dysplasia (HGD) using a balloon-based ablation system for patients undergoing esophagectomy. METHODS: Immediately before esophagectomy, patients underwent ablation of circumferential segments of the esophagus containing IM-HGD using the HALO360 system. The treatment settings were randomized to 10, 12, or 14 J/cm2 for two, three, or four applications. After esophagectomy, multiple sections from ablation zones were microscopically evaluated. Histologic end points included maximum ablation depth (histologic layer) and complete ablation of all IM-HGD (yes/no). RESULTS: Eight men with a mean age of 57 years (range, 45-71 years) were treated, and 10 treatment zones were created. There were no device-related adverse events. At resection, there was no evidence of a transmural thermal effect. Grossly, ablation zones were clearly demarcated sections of ablated epithelium. The maximum ablation depth was the lamina propria or muscularis mucosae. The highest energy (14 J/cm2, 4 applications) incurred edema in the superficial submucosa, but no submucosa ablation. Complete ablation of IM and HGD occurred in 9 of 10 ablation zones (90%), defined as complete removal of the epithelium with only small foci of "ghost cells" representing nonviable, ablated IM-HGD and demonstrating loss of nuclei and cytoarchitectural derangement. One focal area of viable IM-HGD remained at the margin of one ablation zone (12 J/cm2, 2 applications) because of incomplete overlap. CONCLUSION: Complete ablation of IM-HGD without ablation of submucosa is possible using the HALO360 system. Ablation depth is dose related and limited to the muscularis mucosae. In one patient, small residual foci of IM-HGD at the edge of the ablation zone were attributable to incomplete overlap, which can be avoided. This study, together with nonesophagectomy IM-HGD trials currently underway, will identify the optimal treatment parameters for IM-HGD patients who would otherwise undergo esophagectomy or photodynamic therapy.


Asunto(s)
Esófago de Barrett/patología , Esófago de Barrett/cirugía , Ablación por Catéter/instrumentación , Neoplasias Esofágicas/patología , Neoplasias Esofágicas/cirugía , Esofagectomía/instrumentación , Anciano , Esófago de Barrett/mortalidad , Biopsia con Aguja , Cateterismo/instrumentación , Diseño de Equipo , Seguridad de Equipos , Neoplasias Esofágicas/mortalidad , Esofagectomía/métodos , Estudios de Seguimiento , Humanos , Inmunohistoquímica , Masculino , Metaplasia/patología , Persona de Mediana Edad , Invasividad Neoplásica/patología , Medición de Riesgo , Análisis de Supervivencia , Resultado del Tratamiento
8.
Transplant Proc ; 38(9): 3140-3, 2006 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-17112921

RESUMEN

Hepatocellular carcinoma (HCC) recurs in 10% to 60% of the patients after liver transplantation (OLT) and is associated with increased mortality. The average time to recurrence ranges from 1 to 2 years following OLT, and the median survival from the time of diagnosis is about 1 year. We report a case of a 69-year-old man who underwent OLT for hepatitis C virus-related cirrhosis with HCC, and was diagnosed with recurrent HCC 6.5 years after OLT. Biopsies from the initial and recurrent tumors showed a well-differentiated HCC with foci of clear cell pattern. The patient was still alive and asymptomatic 32 months after the diagnosis despite extensive tumor burden. He expired 9 years, 9 months after OLT and 3 years, 2 months after the detection of recurrence. In conclusion, HCC may recur more than 6 years after OLT and may exhibit an indolent course. This case illustrates the highly variable rate of tumor growth and progression post-OLT. The impact of this information on the need for long-term surveillance for recurrent HCC post-OLT remains to be determined.


Asunto(s)
Carcinoma Hepatocelular/cirugía , Neoplasias Hepáticas/cirugía , Trasplante de Hígado/efectos adversos , Anciano , Biopsia , Carcinoma Hepatocelular/patología , Resultado Fatal , Humanos , Neoplasias Hepáticas/patología , Imagen por Resonancia Magnética , Masculino , Recurrencia , Factores de Tiempo
9.
Transplant Proc ; 38(6): 1683-4, 2006.
Artículo en Inglés | MEDLINE | ID: mdl-16908246

RESUMEN

In 2003, an international collection of pathologists and clinicians proposed a unified grading system for acute cellular rejection in endoscopically derived small intestine allograft biopsies. This grading system was implemented at the University of Miami over the past 2 years and the results are presented herein. A total of 1136 small bowel allograft biopsies with sufficient tissue for analysis were obtained from 123 hospitalized, clinic, and referral patients. The overall most common diagnosis assessing all time periods was grade IND (40%), and grade 1 rejection or greater was present in 19% percent of biopsies. A suspected vascular component to the acute rejection as identified by specific mucosal vascular changes was present in 6% of cases. Clinical decision making was very consistent with different grades. Our experience has confirmed that this new grading system is reliable and identifies clinical subsets of patients that can receive different therapy. We recommend that this international grading system be implemented for acute cellular rejection in bowel allografts as a means to standardize pathological assessment of alloimmune-induced graft injury, which will allow comparisons between different centers and clinical trials.


Asunto(s)
Rechazo de Injerto/clasificación , Rechazo de Injerto/patología , Intestino Delgado/trasplante , Trasplante Homólogo/inmunología , Florida , Humanos
10.
Transplant Proc ; 38(5): 1440-4, 2006 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-16797327

RESUMEN

Nonalcoholic fatty liver disease (NAFLD) and the metabolic syndrome (MS) have been shown to play a role in disease progression and response to therapy in patients with chronic hepatitis C virus (HCV) infection. The primary objective of this study was to evaluate the impact of coexisting NAFLD and MS on the progression of fibrosis in patients with recurrent HCV treated with interferon (IFN)/ribavirin after orthotopic liver transplantation (OLT). From 1998 to 2004, a total of 418 patients underwent OLT in our center for HCV-related cirrhosis. Thirty-five patients with recurrent HCV on IFN/ribavirin treatment, who had at least 2 posttransplant liver biopsies at least 6 months apart, were included in the study. Patients who had MS at the time of their first posttransplant biopsy were identified. The first and last posttransplant biopsies were assessed for the presence and severity of NAFLD, grade of inflammation, and stage of fibrosis. The fibrosis progression rate (FPR) was calculated and expressed in fibrosis units per month (FU/mo). Among 35 patients, 34% were diagnosed with NAFLD in the first posttransplant biopsy. The mean FPR was 0.05+/-0.16 FU/mo in the presence of NAFLD compared to 0.07+/-0.10 FU/mo in its absence (P=.68) and 0.03+/-0.06 FU/mo in the presence of MS versus 0.10+/-0.15 FU/mo in its absence (P=.06). When FPR values were divided into two categories of <0.16 FU/mo or >or=0.16 FU/mo (below/above the 25% upper quartile) or <0.08 FU/mo or >or=0.08 FU/mo (below/above the 50% upper quartile), there was no correlation between FPR categories and the presence of NAFLD with or without MS, only MS, or the absence of both in the first liver transplant biopsy (P=.13). Coexisting NAFLD or MS had no significant effect on the progression of fibrosis after OLT in patients with treated hepatitis C after OLT.


Asunto(s)
Hígado Graso/complicaciones , Hepatitis C/epidemiología , Hepatitis C/cirugía , Cirrosis Hepática/epidemiología , Cirrosis Hepática/cirugía , Síndrome Metabólico/complicaciones , Complicaciones Posoperatorias/epidemiología , Adulto , Antivirales/uso terapéutico , Biopsia , HDL-Colesterol/sangre , Progresión de la Enfermedad , Femenino , Hepatitis C/patología , Humanos , Donadores Vivos , Masculino , Persona de Mediana Edad , Recurrencia , Estudios Retrospectivos , Ribavirina/uso terapéutico , Triglicéridos/sangre
11.
Surg Endosc ; 20(1): 125-30, 2006 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-16333533

RESUMEN

BACKGROUND: The goal of this study was to determine the optimal treatment parameters for the ablation of human esophageal epithelium using a balloon-based bipolar radiofrequency (RF) energy electrode. METHODS: Immediately prior to esophagectomy, subjects underwent esophagoscopy and ablation of two separate, 3-cm long, circumferential segments of non-tumor-bearing esophageal epithelium using a balloon-based bipolar RF energy electrode (BARRX Medical, Inc., Sunnyvale, CA, USA). Subjects were randomized to one of three energy density groups: 8, 10, or 12 J/cm2. RF energy was applied one time (1x) proximally and two times (2x) distally. Following resection, sections from each ablation zone were evaluated using H&E and diaphorase. Histological endpoints were complete epithelial ablation (yes/no), maximum ablation depth, and residual ablation thickness after tissue slough. Outcomes were compared according to energy density group and 1x vs 2x treatment. RESULTS: Thirteen male subjects (age, 49-85 years) with esophageal adenocarcinoma underwent the ablation procedure followed by total esophagectomy. Complete epithelial removal occurred in the following zones: 10 J/cm2 (2x) and 12 J/cm2 (1x and 2x). The maximum depth of injury was the muscularis mucosae: 10 and 12 J/cm2 (both 2x). A second treatment (2x) did not significantly increase the depth of injury. Maximum thickness of residual ablation after tissue slough was only 35 microm. CONCLUSIONS: Complete removal of the esophageal epithelium without injury to the submucosa or muscularis propria is possible using this balloon-based RF electrode at 10 J/cm2 (2x) or 12 J/cm2 (1x or 2x). A second application (2x) does not significantly increase ablation depth. These data have been used to select the appropriate settings for treating intestinal metaplasia in trials currently under way.


Asunto(s)
Adenocarcinoma/cirugía , Ablación por Catéter/instrumentación , Neoplasias Esofágicas/cirugía , Esofagectomía/métodos , Esófago/cirugía , Anciano , Anciano de 80 o más Años , Electrodos , Epitelio/cirugía , Diseño de Equipo , Esofagoscopía , Esófago/patología , Humanos , Masculino , Persona de Mediana Edad , Periodo Posoperatorio , Reoperación , Resultado del Tratamiento
12.
Transplant Proc ; 37(2): 1203-4, 2005 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-15848669

RESUMEN

BACKGROUND: We report our experience with Campath 1H in adult liver allotransplantation. METHODS: Between December 2001 and February 2004, 77 patients underwent liver transplantation using Campath 1H induction and low-dose maintenance tacrolimus immunosuppression. The control group consisted of 50 patients with similar baseline characteristics and the same eligibility criteria, transplanted under our standard Tacrolimus/steroids regimen. Hepatitis C patients were excluded from the study. RESULTS: Patient and graft survival were similar for both groups. The incidence of rejection was significantly lower in the Campath vs the control group (51% vs 65% at 12 months, P = .009). Tacrolimus trough levels and conversion from Tacrolimus or the addition of other immunosuppressive drugs due to nephrotoxicity were also significantly lower in the Campath 1H group. CONCLUSION: Campath 1H induction with low-dose Tacrolimus maintenance immunosuppression is an effective regimen in reducing acute rejection in adult liver transplantation, while maintaining lower tacrolimus levels and less nephrotoxicity than our conventional immunosuppressive regimen.


Asunto(s)
Anticuerpos Monoclonales/uso terapéutico , Anticuerpos Antineoplásicos/uso terapéutico , Inmunosupresores/uso terapéutico , Trasplante de Hígado/inmunología , Adulto , Alemtuzumab , Anticuerpos Monoclonales Humanizados , Quimioterapia Combinada , Femenino , Estudios de Seguimiento , Rechazo de Injerto/prevención & control , Supervivencia de Injerto , Humanos , Trasplante de Hígado/mortalidad , Masculino , Estudios Retrospectivos , Análisis de Supervivencia , Tacrolimus/uso terapéutico , Factores de Tiempo , Trasplante Homólogo/inmunología
13.
Transplant Proc ; 35(8): 3057-60, 2003 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-14697979

RESUMEN

BACKGROUND: Acute rejection of human small bowel allografts is characterized by clinical symptoms combined with characteristic morphologic alterations. The typical geographic distribution of acute rejection in the bowel is involvement of the intestinal parenchyma, which can be transmural, particularly when the rejection is more severe. However, little is known concerning the potential for donor-derived soft tissue adjacent to the bowel to become involved by the host alloimmune response. METHODS: We describe a male patient who, several weeks after combined small bowel and liver transplantation, demonstrated sclerosing mesenteritis with vasculitis and acute rejection of the bowel. RESULTS: The vascular lesions in the mesentery demonstrated increased IgG deposition and the patient developed an alloantibody to the donor. CONCLUSIONS: The changes described herein may represent a novel presentation of acute vascular rejection.


Asunto(s)
Rechazo de Injerto/patología , Intestino Delgado/patología , Intestino Delgado/cirugía , Paniculitis Peritoneal/patología , Paniculitis Peritoneal/cirugía , Trasplante Homólogo/patología , Enfermedad Aguda , Adulto , Humanos , Masculino , Nutrición Parenteral Total , Reoperación , Esclerosis , Síndrome del Intestino Corto/patología , Síndrome del Intestino Corto/cirugía
14.
Rev Esp Enferm Dig ; 95(12): 863-75, 2003 Dec.
Artículo en Inglés, Español | MEDLINE | ID: mdl-14972007

RESUMEN

INTRODUCTION: Colonoscopy and bowel preparation cause a number of serum electrolytes changes. AIMS: To determine the prevalence of these changes in patients who underwent colonoscopy and to identify risk factors for these effects. PATIENTS AND METHODS: Forty five patients undergoing colonoscopy were assessed prospectively. They have been previously randomized to receive either sodium phosphate (NaP) or polyethylene glycol (PEG) as preparation. Serum levels of sodium and potassium were analyzed before colonoscopy, immediately after the end of colonoscopy, and 1 hour thereafter. Serum calcium and phosphorus levels were measured just before colonoscopy. RESULTS: Twenty five patients (55.5%) received PEG and 17 (37.7%) NaP. Three patients (6.6%) did not follow the recommended bowel preparation instructions and were excluded from the study. Five patients (11%) developed hyponatremia, of whom, in 4 cases (8.8%), it occurred after the procedure. Thirteen patients (28.8%) developed hypokalemia, of whom it occurred after the end of the procedure in seven (15.5%). There was a non-significant trend to decreased serum potassium levels 1 hour after colonoscopy in patients prepared with NaP (63.6 vs 36.4%). The multivariate analysis showed that low potassium levels were independently associated with age and NaP preparation. Hypocalcemia was observed in 2 patients (4%) and hypophosphatemia in 8 (18%). Hyperphosphatemia was found in 8 cases (18%). Non-significant increases in phosphorus levels were observed in the NaP group. CONCLUSIONS: Temporal sequences of the development of serum electrolyte disturbances suggest that colonoscopy itself might play a role in the pathogenesis of these changes. Preparation for colonoscopy with NaP and the age of patients are risk factors for the development of hypokalemia.


Asunto(s)
Colonoscopía/efectos adversos , Desequilibrio Hidroelectrolítico/etiología , Adolescente , Adulto , Factores de Edad , Anciano , Anciano de 80 o más Años , Colon , Femenino , Humanos , Masculino , Persona de Mediana Edad , Potasio/sangre , Prevalencia , Factores de Riesgo , Sodio/sangre , Soluciones , Irrigación Terapéutica/métodos , Desequilibrio Hidroelectrolítico/epidemiología
15.
Am J Gastroenterol ; 96(11): 3158-64, 2001 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-11721765

RESUMEN

OBJECTIVE: Clinical management of liver diseases is often based on the interpretation of the pathologist examining liver biopsies. Many pathologists have little formal training and experience with these tissues. The magnitude of this problem is not determined yet. The goal of this study was to determine the diagnostic discrepancies that surfaced after a second opinion by experienced hepatopathologists interpreting liver biopsy tissues. METHODS: All 178 consecutive liver biopsy tissue glass slides provided to hepatology consultants in 1996 and 1997 were selected for evaluation. Specimens with neoplasms, transplant-related indications, or those specifically referred by a community-based pathologist for consultation were excluded. Diagnosis and interpretations were compared with the reports from the original institutions. Discordant interpretations were grouped in major (description or diagnosis that would change management decisions) and minor (not likely to alter management) categories. Monetary cost of the pathology studies was analyzed. RESULTS: A total of 125 specimens corresponding to 124 patients met inclusion criteria. Thirty-five (28%) and 47 (37.6%) biopsies had major and minor discrepancies, respectively. Full agreement was obtained in 43 (34.4%) cases. Fifteen (42.8%) of the major interpretation errors were on patients with chronic cholestatic disorders, nine (25.7%) with hepatocellular processes, and 11 (31.4%) were related to establishing the presence or absence of cirrhosis. Reviewing the 125 liver biopsies of this study by the consultants resulted in a 46% increase in monetary cost. CONCLUSIONS: Practitioners making clinical decisions based on liver biopsy interpretation need to be aware that in a significant number of cases, pathologists are not able to arrive at a correct diagnosis, and thus seeking second opinions on the patients' behalf from experienced pathologists on liver diseases would be prudent. General pathologists should become more familiar with the abnormalities involving interlobular bile ducts and the diagnostic value of certain ancillary histological stains. Clinicians should provide pathologists with sufficient clinical information in terms of laboratory evaluations and clinical findings, so that accurate diagnosis might be facilitated.


Asunto(s)
Hepatopatías/patología , Hígado/patología , Derivación y Consulta , Adulto , Anciano , Biopsia/economía , Biopsia/estadística & datos numéricos , Costos y Análisis de Costo , Interpretación Estadística de Datos , Femenino , Humanos , Masculino , Persona de Mediana Edad , Variaciones Dependientes del Observador
16.
Appl Immunohistochem Mol Morphol ; 8(3): 189-94, 2000 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-10981870

RESUMEN

Thyroid transcription factor-1 (TTF-1), a member of the NKx2 family of homeodomain transcription factors, is a mediator of thyroid-specific transcription of the thyroglobulin (TG) gene. The combined immunohistochemical profile of TTF-1, TG, cytokeratin 7 (CK7), and cytokeratin 20 (CK20) in neoplasms of the thyroid gland and their metastases to other sites has not been defined previously. Formalin-fixed tissue of 43 thyroid tumors, including 31 carcinomas and 12 adenomas, and 16 metastasic lesions were immunostained using monoclonal antibodies to TTF-1, TG, CK7, and CK20. Immunoreactivity of the primary tumors (adenomas and carcinomas) for TTF-1 was seen in 32 cases (74%), TG 32 (74%), and CK7 34 (79%), whereas none (0%) showed positivity for CK20. The distribution of reactivity in the 31 carcinomas for TTF-1, TG, and CK7, respectively was papillary (8/8), (8/8), and (8/8); poorly differentiated (6/7), (4/7), and (6/7); oncocytic (Hürthle) cell (2/6), (6/6), and (4/6); follicular (4/4), (3/4), and (3/4); medullary (1/2), (0/2), and (1/2). One of four anaplastic carcinomas was focally immunoreactive showing positivity for TTF-1 only. Of the six follicular adenomas, five were positive for TTF-1, six for TG, and six for CK7. Among the six oncocytic cell adenomas, five were reactive for TTF-1, five for TG, and all six for CK7. Twelve (75%) of the 16 metastatic tumors were positive for TTF-1, 10 (63%) for TG, 15 (94%) for CK7, and none (0%) for CK20. In summary, TTF-1 and TG are demonstrable by immunohistochemistry in the majority of thyroid neoplasms. Compared with TG, an antibody to TTF-I is a similarly sensitive marker for thyroid tumors. Moreover, TTF-1 is a more sensitive marker for poorly differentiated carcinomas and metastasis. In most cases, its nuclear pattern of immunoreactivity facilitates interpretation. Thyroid tumors are CK7+/CK20-. The panel of antibodies for TG, TTF-1, CK7, and CK20 is useful when the thyroid origin of a metastatic tumor is a consideration.


Asunto(s)
Adenoma/metabolismo , Carcinoma/metabolismo , Queratinas/biosíntesis , Proteínas Nucleares/biosíntesis , Tiroglobulina/biosíntesis , Neoplasias de la Tiroides/metabolismo , Factores de Transcripción/biosíntesis , Adenoma/patología , Carcinoma/patología , Humanos , Inmunohistoquímica , Neoplasias de la Tiroides/patología , Factor Nuclear Tiroideo 1
17.
Arch Pathol Lab Med ; 124(8): 1179-84, 2000 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-10923080

RESUMEN

CONTEXT: Hyalinizing spindle cell tumor with giant rosettes is a recently described biphasic neoplasm of soft tissues that shares mesenchymal and neuroendocrine features. Its morphologic structure is distinctive, with the presence of hyalinized paucicellular foci that are termed rosettes. The cells around the latter display positive immunoreactivity for neuroendocrine markers. The small number of cases described to date indicates that they tend to be localized in the extremities. OBJECTIVE: To describe the clinicopathologic features of 2 unusual cases of hyalinizing spindle cell tumor with giant rosettes. METHODS AND RESULTS: One tumor was located in the prestyloid parapharyngeal space and the second in the left thigh. Both tumors were well circumscribed and surrounded by a thin capsule-like fibrous band without infiltrating projections. The rosettes were embedded in a spindle cell proliferation. Immunohistochemical stains showed positive results for S100 protein, synaptophysin, CD57, protein gene product 9.5, and neuron-specific enolase exclusively in the cells palisading the rosettes. These markers were negative in the spindle cell portions of the tumor. The latter were immunoreactive for factor XIIIa, vimentin, HAM56, collagen IV, and CD68. Vimentin was the only marker shared by the rosette-forming cells and the spindle cells. Ultrastructurally, the rosette-forming cells contained neurosecretory granules. This study describes the first cytogenetic analysis in this type of tumor revealing 2 cell lines, both containing a balanced translocation between chromosomes 7 and 16. Follow-up of the patients at 16 and 8 months did not disclose evidence of recurrence. CONCLUSIONS: These 2 new cases increase the awareness of hyalinizing spindle cell tumor with giant rosettes and demonstrate that it is a spindle cell neoplasm of unique cytogenetic rearrangements composed of dendritic, histiocytic, and fibroblastic cells admixed with cells that have neuroendocrine differentiation.


Asunto(s)
Citoplasma/ultraestructura , Mesodermo/patología , Tumores Neuroendocrinos/patología , Neoplasias Faríngeas/patología , Neoplasias de los Tejidos Blandos/patología , Adulto , Biomarcadores de Tumor/metabolismo , Femenino , Humanos , Inmunohistoquímica , Cariotipificación , Persona de Mediana Edad , Neoplasias de los Músculos/metabolismo , Neoplasias de los Músculos/patología , Neoplasias de los Músculos/cirugía , Tumores Neuroendocrinos/metabolismo , Tumores Neuroendocrinos/cirugía , Neoplasias Faríngeas/metabolismo , Neoplasias Faríngeas/cirugía , Formación de Roseta , Neoplasias de los Tejidos Blandos/metabolismo , Neoplasias de los Tejidos Blandos/cirugía , Muslo/patología , Translocación Genética
18.
Am J Surg Pathol ; 24(7): 1009-15, 2000 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-10895824

RESUMEN

Despite being relatively common in the rectum, foamy histiocytes have received scant attention as to the antecedent lesion that causes them to form or their histologic characterization on the types of muco-substances they accumulate. One-hundred consecutive tissue sections of the rectum from an equal number of patients were reviewed for the presence of foamy histiocytes, evaluated for their associated histologic features, and examined histochemically for five types of mucin. Immunohistochemical and electron microscopic studies were performed. Forty (40%) of the rectal biopsy tissues contained foamy histiocytes. Patients presented with diarrhea, hematochezia, intestinal habit change, constipation, hemorrhoids, and abdominal pain. Endoscopically, 19 patients were thought to have rectal nodules or polyps. Histologically, 25 of the patients had regenerative changes in the adjacent mucosa and 14 had hyperplastic changes. In 36 patients (90%), the foamy histiocytes were located superficially in the lamina propria. Associated changes indicated that they are found in areas that are subject to an injury that is in a healing phase. These changes included mild fibrosis and chronic inflammation of lamina propria with mild architectural distortion. Thirty-five (88%) cases showed staining for D-PAS, Alcian blue stain pH 2.5, and the cocktail Alcian blue stain/PAS. Mucicarmine was positive in 25 (63%) cases. The Alcian blue stain pH 1.0 was positive in 19 (59%) of 32 cases. Ultrastructural studies showed electron-dense globules. Two cases were histologically identical to the other 38 but they did not stain for any mucin. Ultrastructural features disclosed clear vacuoles and thus represent a xanthelasma of the rectum. The foamy cells in all cases were confirmed to be histiocytes by immunohistochemistry and electron microscopy. Although muciphages and xanthelasma of the rectum may mimic polyps endoscopically, they are not related to any specific symptom or clinical finding, despite the fact that they probably represent remnants of a previous injury. Muciphages contain neutral, weakly acidic or strongly acidic mucin. The main type of acidic mucin is sialomucin with a smaller component of sulfated mucin.


Asunto(s)
Células Espumosas/patología , Histiocitos/patología , Mucinas/metabolismo , Enfermedades del Recto/patología , Recto/patología , Xantomatosis/patología , Adulto , Anciano , Anciano de 80 o más Años , Femenino , Células Espumosas/metabolismo , Histiocitos/metabolismo , Humanos , Técnicas para Inmunoenzimas , Masculino , Persona de Mediana Edad , Enfermedades del Recto/metabolismo , Recto/metabolismo , Xantomatosis/metabolismo
19.
Am J Clin Oncol ; 23(2): 140-2, 2000 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-10776973

RESUMEN

This is the first clinical case report of a thoracic invasive thymoma metastatic to the ovary with disease noted in the entire abdomen including the pelvis 5 1/2 years after initial diagnosis. The involved areas of metastases include the distal ileum, peritoneal and serosal surfaces (including the surface of the distal colon, bladder, and pelvis), and the surface of the right ovary. The patient survived 13 years after her initial diagnosis and 7 1/2 years after discovery of her metastases. Thymomas are rare tumors but comprise the most common primary tumor of the anterior mediastinum. Extrathoracic metastases of malignant thymomas are also rare, and the literature reports that the most common sites for metastases are the liver, lung, lymph nodes, and bone. Extrathoracic disease is associated with a poor prognosis. The average time of survival after the diagnosis of metastases is 1.5 years.


Asunto(s)
Neoplasias Gastrointestinales/secundario , Neoplasias Ováricas/secundario , Timoma/secundario , Neoplasias del Timo/patología , Adulto , Femenino , Humanos , Pronóstico , Factores de Tiempo
20.
Arch Pathol Lab Med ; 124(3): 431-4, 2000 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-10705401

RESUMEN

Female adnexal tumor of probable wolffian origin is a rare neoplasm that can present diagnostic difficulties. We report herein a case of a 60-year-old woman with female adnexal tumor of probable wolffian origin arising within the leaves of a broad ligament and, 5 years later, presenting with metastasis to the liver. The morphologic, immunohistochemical, ultrastructural, and DNA ploidy findings of the original and metastatic tumor, differential diagnoses, and the results of the English-language literature review are presented.


Asunto(s)
Adenoma/patología , Neoplasias Hepáticas/secundario , Neoplasias Ováricas/patología , Conductos Mesonéfricos/patología , Adenoma/química , Adenoma/genética , Biomarcadores de Tumor/análisis , Cistadenocarcinoma Papilar/patología , ADN de Neoplasias/análisis , Errores Diagnósticos , Femenino , Humanos , Inmunohistoquímica , Neoplasias Hepáticas/química , Neoplasias Hepáticas/genética , Persona de Mediana Edad , Neoplasias Ováricas/química , Neoplasias Ováricas/genética , Neoplasias Ováricas/cirugía , Ploidias , Posmenopausia , Conductos Mesonéfricos/química
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...